Stocks · News reference
Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 GAAP EPS of $2.98-$3.22 vs $3.00 analyst estimate..
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Phibro Animal Health (PAHC) is gaining momentum from strong Animal Health segment growth, driven by the Zoetis MFA acquisition, vaccine expansion, and mineral nutrition demand recovery. However, the company faces headwinds from macroeconomic risks, trade policy uncertainties, and foreign exchange volatility that continue to pressure reported results.
Phibro Animal Health (NASDAQ:PAHC) held its fourth-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access
MFA SITE CLOSUREThrough the MFA acquisition in 2024, Phibro added several manufacturing facilities. Since then, we have conducted a comprehensive review of our manufacturing network to ensure our production footprint is
Filed: 2026-08-26 AccNo: 0001104659-26-101531 Size: 916 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits